Changes in DNA methylation patterns occur early during oncogenesis, and each type of cancer has its own methylomic signature. Technological advances in methylation sequencing, or methyl-seq, allow researchers to quickly characterize methylation patterns in specific regions of interest and identify potential biomarkers for cancer screening.
